NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,000 | -27.3% | 15,770 | -2.1% | 0.00% | – |
| Q2 2020 | $11,000 | -71.8% | 16,114 | -69.1% | 0.00% | – |
| Q1 2020 | $39,000 | -11.4% | 52,130 | +80.3% | 0.00% | – |
| Q4 2019 | $44,000 | -26.7% | 28,919 | -28.9% | 0.00% | – |
| Q3 2019 | $60,000 | -89.5% | 40,680 | -90.9% | 0.00% | -100.0% |
| Q2 2019 | $574,000 | -32.1% | 445,039 | +37.4% | 0.00% | 0.0% |
| Q1 2019 | $845,000 | +478.8% | 323,824 | +265.3% | 0.00% | – |
| Q4 2018 | $146,000 | -57.4% | 88,643 | +25.4% | 0.00% | – |
| Q3 2018 | $343,000 | -67.7% | 70,716 | -58.4% | 0.00% | -100.0% |
| Q2 2018 | $1,063,000 | +104.8% | 170,045 | +171.9% | 0.00% | 0.0% |
| Q1 2018 | $519,000 | -94.7% | 62,530 | -94.1% | 0.00% | -93.3% |
| Q3 2017 | $9,779,000 | +125.8% | 1,068,725 | +80.1% | 0.02% | +87.5% |
| Q2 2017 | $4,331,000 | +9.2% | 593,278 | +7.7% | 0.01% | +14.3% |
| Q1 2017 | $3,966,000 | +128.9% | 550,868 | +86.0% | 0.01% | +75.0% |
| Q4 2016 | $1,733,000 | -12.2% | 296,175 | -1.3% | 0.00% | +33.3% |
| Q3 2016 | $1,974,000 | +590.2% | 300,000 | +2101.4% | 0.00% | +200.0% |
| Q3 2015 | $286,000 | – | 13,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|